Key result
(-)-Epicatechin-3-gallate (ECG) blocks multiple stages of carcinogenesis by regulating intracellular signaling transduction pathways, highlighting its potential as an anticarcinogenic agent.
This review highlights the potential of ECG as an anticarcinogenic agent through its interaction with cellular signal transduction pathways.
No takes yet. Share an insight, caveat, or question.
Should not yet change practice; leaves open need for human trials to confirm ECG's anticarcinogenic potential.
Pan et al. (2011) conducted a review in Cancer. (-)-Epicatechin-3-gallate (ECG) was evaluated. (-)-Epicatechin-3-gallate (ECG) blocks multiple stages of carcinogenesis by regulating intracellular signaling transduction pathways, highlighting its potential as an anticarcinogenic agent.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: